Lipocine Inc
LPCN8.490USD
+0.770+9.97%
Cierre 02/06, 16:00（ET）Cotizaciones retrasadas 15 min
46.02MCap. mercado
PérdidaP/E TTM
Más Datos de Lipocine Inc Compañía
Lipocine Inc. is a biopharmaceutical company leveraging its proprietary technology platform to enable effective oral delivery of therapeutics. The Company’s clinical development candidates include: LPCN 1154, oral brexanolone, for the treatment of postpartum depression, LPCN 2101, for the treatment of epilepsy, LPCN 2203, an oral candidate targeted for the management of essential tremor, LPCN 2401, an oral proprietary anabolic androgen receptor agonist for improved body composition in obesity management, and LPCN 1148, for the management of decompensated cirrhosis. It is also developing LPCN 1107, for the prevention of preterm birth, LPCN 1154, for rapid relief of postpartum depression, and LPCN 1144, for the treatment of metabolic dysfunction-associated steatohepatitis. Its product candidate, TLANDO, is a novel oral prodrug of testosterone containing testosterone undecanoate developed by the Company.
Información de Lipocine Inc
Símbolo de cotizaciónLPCN
Nombre de la empresaLipocine Inc
Fecha de salida a bolsaMar 21, 2014
Director ejecutivoPatel (Mahesh V)
Número de empleados16
Tipo de seguridadOrdinary Share
Fin del año fiscalMar 21
Dirección675 S Arapeen Dr Ste 202
CiudadSALT LAKE CITY
Bolsa de valoresNASDAQ OMX - NASDAQ BASIC
PaísUnited States of America
Código postal84108-1295
Teléfono18019947383
Sitio Webhttps://www.lipocine.com/
Símbolo de cotizaciónLPCN
Fecha de salida a bolsaMar 21, 2014
Director ejecutivoPatel (Mahesh V)
Ejecutivos de Lipocine Inc
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Dr. Mahesh V. Patel, Ph.D.
Dr. Mahesh V. Patel, Ph.D.
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
109.05K
+1630.00%
Mr. John W. Higuchi
Mr. John W. Higuchi
Director
Director
40.80K
--
Dr. Nachiappan Chidambaram, Ph.D.
Dr. Nachiappan Chidambaram, Ph.D.
Senior Vice President - Research and Development
Senior Vice President - Research and Development
4.41K
+456.00%
Ms. Krista Fogarty
Ms. Krista Fogarty
Principal Accounting Officer, Corporate Controller
Principal Accounting Officer, Corporate Controller
1.07K
+330.00%
Dr. Richard Dana Ono, Ph.D.
Dr. Richard Dana Ono, Ph.D.
Independent Director
Independent Director
831.00
--
Mr. Jeffrey A. (Jeff) Fink
Mr. Jeffrey A. (Jeff) Fink
Independent Director
Independent Director
386.00
--
Dr. Jill M. Jene, Ph.D.
Dr. Jill M. Jene, Ph.D.
Independent Director
Independent Director
--
--
Mr. Spyros Papapetropoulos, M.D., Ph.D.
Mr. Spyros Papapetropoulos, M.D., Ph.D.
Lead Independent Chairman of the Board
Lead Independent Chairman of the Board
--
--
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Dr. Mahesh V. Patel, Ph.D.
Dr. Mahesh V. Patel, Ph.D.
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
109.05K
+1630.00%
Mr. John W. Higuchi
Mr. John W. Higuchi
Director
Director
40.80K
--
Dr. Nachiappan Chidambaram, Ph.D.
Dr. Nachiappan Chidambaram, Ph.D.
Senior Vice President - Research and Development
Senior Vice President - Research and Development
4.41K
+456.00%
Ms. Krista Fogarty
Ms. Krista Fogarty
Principal Accounting Officer, Corporate Controller
Principal Accounting Officer, Corporate Controller
1.07K
+330.00%
Dr. Richard Dana Ono, Ph.D.
Dr. Richard Dana Ono, Ph.D.
Independent Director
Independent Director
831.00
--
Mr. Jeffrey A. (Jeff) Fink
Mr. Jeffrey A. (Jeff) Fink
Independent Director
Independent Director
386.00
--
Desglose de ingresos
La empresa aún no ha revelado los datos relevantes.
La empresa aún no ha revelado los datos relevantes.
Por negocio
Por región
La empresa aún no ha revelado los datos relevantes.
Estadísticas de accionistas
Actualizado: sáb., 27 de dic
Actualizado: sáb., 27 de dic
Accionistas
Tipos de accionistas
Accionistas
Accionistas
Proporción
Squadron Capital Management LLC
9.01%
The Vanguard Group, Inc.
4.00%
Patel (Mahesh V)
1.96%
BlackRock Institutional Trust Company, N.A.
1.61%
Geode Capital Management, L.L.C.
1.10%
Otro
82.33%
Accionistas
Accionistas
Proporción
Squadron Capital Management LLC
9.01%
The Vanguard Group, Inc.
4.00%
Patel (Mahesh V)
1.96%
BlackRock Institutional Trust Company, N.A.
1.61%
Geode Capital Management, L.L.C.
1.10%
Otro
82.33%
Tipos de accionistas
Accionistas
Proporción
Investment Advisor
15.84%
Individual Investor
2.84%
Investment Advisor/Hedge Fund
1.89%
Hedge Fund
0.93%
Otro
78.50%
Participación institucional
Actualizado: jue., 1 de ene
Actualizado: jue., 1 de ene
Periodo del informe
Número de instituciones
Acciones mantenidas
Proporción
Cambio
2025Q4
32
1.04M
18.66%
+478.43K
2025Q3
32
528.39K
9.52%
-40.19K
2025Q2
44
680.47K
12.56%
-41.55K
2025Q1
65
678.55K
12.68%
-110.89K
2024Q4
72
645.33K
12.07%
-219.30K
2024Q3
75
703.77K
13.16%
-136.61K
2024Q2
79
690.86K
12.92%
-132.01K
2024Q1
82
639.82K
12.02%
-214.82K
2023Q4
86
649.80K
12.29%
-222.39K
2023Q3
91
667.07K
12.61%
-176.35K
Ver más
Actividad de los accionistas
Nombre
Acciones mantenidas
Proporción
Cambio
Cambio %
Fecha
Squadron Capital Management LLC
500.00K
9.01%
+500.00K
--
Dec 18, 2025
The Vanguard Group, Inc.
221.87K
4%
-3.01K
-1.34%
Sep 30, 2025
Patel (Mahesh V)
109.05K
1.96%
+1.63K
+1.52%
Mar 31, 2025
BlackRock Institutional Trust Company, N.A.
89.27K
1.61%
--
--
Sep 30, 2025
Geode Capital Management, L.L.C.
61.08K
1.1%
--
--
Sep 30, 2025
Susquehanna International Group, LLP
46.76K
0.84%
+742.00
+1.61%
Sep 30, 2025
Higuchi (John W)
40.80K
0.73%
--
--
Mar 31, 2025
Renaissance Technologies LLC
36.10K
0.65%
+1.30K
+3.74%
Sep 30, 2025
State Street Investment Management (US)
18.63K
0.34%
--
--
Sep 30, 2025
Citadel Advisors LLC
14.25K
0.26%
+14.25K
--
Sep 30, 2025
Ver más
ETFs relacionados
Actualizado: sáb., 6 de dic
Actualizado: sáb., 6 de dic
Nombre
Proporción
iShares Core S&P Total U.S. Stock Market ETF
0%
DFA Dimensional US Sustainability Core 1 ETF
0%
Dimensional US Core Equity 1 ETF
0%
iShares Core S&P Total U.S. Stock Market ETF
Proporción0%
DFA Dimensional US Sustainability Core 1 ETF
Proporción0%
Dimensional US Core Equity 1 ETF
Proporción0%
Dividendos
Un total de
0.00
USD se ha distribuido en dividendos durante los últimos 5 años.
Fecha
Dividendos
Fecha de registro
Fecha de pago
Fecha ex-dividendo
Sin datos
División de acciones
Fecha
Fecha ex-dividendo
Tipo
Relación
May 11, 2023
Merger
17→1
May 11, 2023
Merger
17→1
May 11, 2023
Merger
17→1
May 11, 2023
Merger
17→1
Fecha
Fecha ex-dividendo
Tipo
Relación
May 11, 2023
Merger
17→1
May 11, 2023
Merger
17→1
May 11, 2023
Merger
17→1
May 11, 2023
Merger
17→1
